Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 -

Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
Information type: Other primary research
Source: The Lancet HIV
Specialities: Infection and infectious diseases
Summary
Study notes despite progress in reducing HIV-related mortality over past decade, slow decreases in incidence, combined with stagnated funding for related interventions, mean many countries are not on track to reach 2020 and 2030 global targets for reduction in incidence/mortality
UKMi comment
Global HIV mortality peaked in 2006 with 1.95m deaths and has since decreased to 0.95m deaths in 2017. New cases of HIV globally peaked in 1999 (3.16m) and since then have gradually decreased to 1.94m in 2017.

According to a commentary, expansion of treatment coverage and preventive measures have reduced HIV burden in many sub-Saharan African countries, but eastern Europe and central Asia, which are less affected by HIV historically, have begun to see an increasing incidence. Particularly, Russia had the highest annualised rate of change in incidence of 13·2% between 2007 and 2017. Similarly, harm reduction services are inadequate in much of eastern Europe and central Asia. It notes that the timely findings of this study call for a reinvigorated effort to galvanise targeted preventive interventions and turn the tide of the HIV pandemic.
Related links: Comment